social linkedin box blue 64social twitter box blue 64

 PRA 108x130 72

Tour So Ouest
35 rue d’Alsace
92300 Levallois-Perret 

www.prahs.com

 Contact : This email address is being protected from spambots. You need JavaScript enabled to view it.

PRA is one of the world's leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and approximately 12,000 employees worldwide. Since 2000, PRA has performed approximately 3,300 clinical trials worldwide and has worked on more than 100 marketed drugs across several therapeutic areas. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 60 drugs.

PRA has therapeutic expertise in areas that are among the largest in pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. PRA believes that it provides its clients with one of the most flexible clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. PRA has invested in medical informatics and clinical technologies designed to enhance efficiencies, improve study predictability and provide better transparency to clients throughout their clinical development processes.

To learn more about PRA, please visit www.prahs.com.

 

Tags: Phase 1, étude post-inscription, Phase 2, Phase 3, Phase 4, Médicament, Dispositif Médical, Biotechnologies, Affaires Règlementaires